| Secondary quality-of-life domains in patients with relapsed and refractory multiple myeloma treated with the Bcma-Directed CAR T cell therapy Idecabtagene Vicleucel (ide-cel … N Shah, M Delforge, JF San-Miguel, KB Bertin, MJ Tahir, HB Lewis, ... Blood 136, 28-29, 2020 | 21 | 2020 |
| Effect of a patient decision aid on preferences for colorectal cancer screening among older adults: A secondary analysis of a randomized clinical trial AF Dalton, CE Golin, C Morris, CE Kistler, RJ Dolor, KB Bertin, K Suresh, ... JAMA Network Open 5 (12), e2244982-e2244982, 2022 | 2 | 2022 |
| Self-Efficacy and readiness to change among women with recent gestational diabetes engaging in a web-based lifestyle intervention: the balance after baby intervention trial CE Saxon, EW Seely, KB Bertin, K Suresh, G Skurnik, AT Roche, ... American Journal of Lifestyle Medicine, 15598276231155147, 2023 | 1 | 2023 |
| Quality of life in patients (pts) with relapsed and refractory multiple myeloma (RRMM) treated with the BCMA-DIRECTED CAR T cell therapy Idecabtagene vicleucel (IDE-CEL, bb2121 … K Weisel, H Einsele, H Goldschmidt, M Delforge, J San Miguel, KB Bertin, ... Oncology Research And Treatment 43 (SUPPL 4), 93-94, 2020 | 1 | 2020 |
| Self-Efficacy and readiness to change among women with recent gestational diabetes engaging in a web-based lifestyle intervention: the balance after baby intervention trial CE Saxon, EW Seely, G Skurnik, A Roche, C Schultz, K Suresh, R Blai, ... JOURNAL OF GENERAL INTERNAL MEDICINE 35 (SUPPL 1), S269-S269, 2020 | 1 | 2020 |
| Using Administrative Billing Codes to Identify Acute Musculoskeletal Infections in Children JB Searns, JD Rice, KB Bertin, M Birkholz, LB Barganier, CB Creech, ... Hospital Pediatrics 13 (2), 182-195, 2023 | | 2023 |
| Patient control preferences for medical decision making before and after evaluation for left ventricular assist device V Krishnan, KB Bertin, CK McIlvennan, JS Thompson, DD Matlock, ... American Heart Journal Plus: Cardiology Research and Practice 26, 100245, 2023 | | 2023 |
| Results from the KarMMa clinical trial: Secondary Quality-of-Life domains in patients (pts) with relapsed and refractory multiple myeloma (RRMM) treated with the BCMA-directed … H Einsele, N Shah, M Delforge, JF San-Miguel, KB Bertin, MJ Tahir, ... Oncology Research And Treatment 44, 206-208, 2021 | | 2021 |
